Winona provides more than a general mention of progesterone: it has a dedicated capsule page with a starting price, ingredient list and answers about prescribing, payment and follow-up. Those details are useful for someone preparing to ask about care. They still need to be read as an offer from a provider, not a prediction of personal results.
Capsule Questions belongs to the CoreAge Rx promotional publishing network, which gives CoreAge first commercial placement. This relationship does not justify a clinical score for Winona or its capsules. The review below uses current public material and primary medical guidance; it does not claim a purchased prescription, patient interview or firsthand trial.
In this article
What is the current offer?
The Winona progesterone capsule page advertises a starting amount of $39 per month. It says prescription products require an online medical evaluation and that a doctor determines whether treatment is appropriate. The page describes an intake process rather than an over-the-counter purchase. A displayed price is not approval for treatment.
For a prospective patient, the first useful question is what that starting amount would cover in the proposed plan. Confirm the prescribed product and quantity, any other hormone medicines, and the applicable billing arrangement. Our care-options comparison keeps an assessment service separate from the product it might prescribe, so a medicine headline is not mistaken for a complete care quote.
What does Winona disclose about capsule ingredients?
Winona lists progesterone USP as the active ingredient. Its inactive-ingredient list includes gelatin, glycerin, hypromellose, iron oxide black, lecithin, peanut oil, propylene glycol and titanium dioxide. The page explicitly says the capsules contain peanut oil and are not vegan because of gelatin. These are disclosures on the specific capsule page, not deductions from a different brand.
A reader with a peanut allergy should raise that information before accepting a prescription and have the actual product checked by the clinician and pharmacist. The excipients guide explains what to obtain. We do not endorse a change to another route based only on a provider’s suggested alternative; the clinical purpose still needs to be met.
How precise is the approval statement?
The capsule FAQ says Winona’s progesterone capsules are FDA approved. The reviewed page does not identify a manufacturer or establish that the product is Prometrium. Winona’s general treatment-method page, meanwhile, describes its pills category using compounding language. The specific capsule statement and the broader category description should not be silently combined into one product identity.
Ask which exact labeled product the pharmacy will dispense and whether it is an approved manufactured medicine or a compounded preparation. The FDA explains that compounded drugs are not FDA approved. That makes the distinction worth resolving; it does not justify declaring that Winona’s specific approval statement is false without identifying the product behind it.
Which treatment claims deserve a narrower reading?
The capsule page surrounds its offer with a broad list of menopause concerns and describes possible sleep and mood benefits. Such marketing should not be read as proof that this capsule alone treats every listed problem or that a reader’s symptoms have one hormonal cause. A capsule’s purpose should be explained within the actual treatment plan.
The FDA hormone-therapy overview distinguishes therapy categories, and ACOG recommends decisions based on symptoms and medical history. Neither source validates every claim on a provider’s page. Our purpose guide helps identify the clinical question, while the drowsiness guide distinguishes a possible effect from a promised sleep outcome.
Is the advertised access the same as immediate clinical advice?
Winona says the prescription includes ongoing access to a doctor and messaging through its patient portal. The capsule page describes messages that can be sent at any time. That does not establish a measured response time, a same-minute medical assessment or a substitute for urgent care. We have not tested the service’s portal or staffing. Service description.
Ask how medication questions are triaged and who responds when the usual clinician is unavailable. Also ask how an existing estrogen prescriber receives relevant updates. A message channel is useful only when the patient knows which concerns belong there and which need another route. The follow-up guide offers a way to clarify those responsibilities.
What should you understand about payment and refills?
The product FAQ says Winona does not bill insurance companies directly. It describes HSA/FSA payment and documentation that a patient can use to seek possible reimbursement. Possible reimbursement is not verified coverage, and a starting price should not be described as an insurance copay.
Winona also describes automatic prescription refills within a subscription, with options to manage the shipping date or cancel. Confirm the billing frequency, quantity and effective timing of changes before relying on those options. A change requested after an order enters processing may raise questions the public summary does not answer. An ongoing subscription is a commercial arrangement, not evidence that a treatment remains clinically appropriate indefinitely.
What does delivery information establish?
The capsule page advertises free standard shipping and optional paid expedited services. It also describes a review period and pharmacy processing before shipment. These stages should remain separate: selecting a shipping speed does not mean that a clinician has prescribed, that the pharmacy has completed its work or that a parcel will arrive by a personally required date. Delivery explanation.
If continuity is important, ask the service to confirm the status of the actual prescription and order. This review provides no safe interruption window or medication workaround. A clinician and pharmacist can address the treatment issue; a shipment estimate cannot. Keep any proposed change in care connected to the current prescriber until responsibilities are clear.
What would make the offer clear enough to evaluate?
A satisfactory answer identifies the capsule, the reason it is being prescribed, its ingredients, the full charges and the person handling follow-up. If the product is named, its exact label can then be reviewed. Our Prometrium article shows that process without claiming Winona supplies that brand.
For comparison, the CoreAge review has different unresolved formulation and price questions. Its commercial position should not determine the clinical conclusion. Winona’s public page supports a current offer and specific disclosures; an individual assessment and a confirmed pharmacy record are still needed to know what someone would actually receive.
Sources for this article
Source type matters. A provider page describes an offer; an exact product label describes that medicine.
- Winona: Progesterone Capsules product, ingredients and service termsProvider product page · Checked 2026-09-27
- Winona: broader treatment-method descriptionsProvider treatment overview · Checked 2026-09-27
- FDA: Understanding the Risks of Compounded DrugsFederal regulator compounding explanation · Checked 2026-09-27
- FDA: Hormone Replacement Therapies Can Help Women with Bothersome Menopausal SymptomsFederal regulator patient information · Checked 2026-09-27
- ACOG: Hormone Therapy for MenopauseMedical society patient guidance · Checked 2026-09-27